These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21738811)

  • 1. Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.
    Cencig S; Coltel N; Truyens C; Carlier Y
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1216. PubMed ID: 21738811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
    Cencig S; Coltel N; Truyens C; Carlier Y
    Int J Antimicrob Agents; 2012 Dec; 40(6):527-32. PubMed ID: 23063742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
    Calvet CM; Choi JY; Thomas D; Suzuki B; Hirata K; Lostracco-Johnson S; de Mesquita LB; Nogueira A; Meuser-Batista M; Silva TA; Siqueira-Neto JL; Roush WR; de Souza Pereira MC; McKerrow JH; Podust LM
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006132. PubMed ID: 29281643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time PCR strategy for parasite quantification in blood and tissue samples of experimental Trypanosoma cruzi infection.
    Caldas S; Caldas IS; Diniz Lde F; Lima WG; Oliveira Rde P; Cecílio AB; Ribeiro I; Talvani A; Bahia MT
    Acta Trop; 2012 Sep; 123(3):170-7. PubMed ID: 22609548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections.
    Yardley V; Croft SL
    Am J Trop Med Hyg; 1999 Aug; 61(2):193-7. PubMed ID: 10463666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
    Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential oils from Syzygium aromaticum and Zingiber officinale, administered alone or in combination with benznidazole, reduce the parasite load in mice orally inoculated with Trypanosoma cruzi II.
    Sarto MPM; Lucas da Silva HF; de Souza Fernandes N; de Abreu AP; Zanusso Junior G; de Ornelas Toledo MJ
    BMC Complement Med Ther; 2021 Feb; 21(1):77. PubMed ID: 33632196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues.
    Silva-Dos-Santos D; Barreto-de-Albuquerque J; Guerra B; Moreira OC; Berbert LR; Ramos MT; Mascarenhas BAS; Britto C; Morrot A; Serra Villa-Verde DM; Garzoni LR; Savino W; Cotta-de-Almeida V; de Meis J
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005507. PubMed ID: 28379959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
    Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
    Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.
    Moreira OC; Ramírez JD; Velázquez E; Melo MF; Lima-Ferreira C; Guhl F; Sosa-Estani S; Marin-Neto JA; Morillo CA; Britto C
    Acta Trop; 2013 Jan; 125(1):23-31. PubMed ID: 22982466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi load in synanthropic rodents from rural areas in Chile.
    Yefi-Quinteros E; Muñoz-San Martín C; Bacigalupo A; Correa JP; Cattan PE
    Parasit Vectors; 2018 Mar; 11(1):171. PubMed ID: 29530074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
    Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO
    Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection.
    Gulin JE; Eagleson MA; Postan M; Cutrullis RA; Freilij H; Bournissen FG; Petray PB; Altcheh J
    J Antimicrob Chemother; 2013 Apr; 68(4):888-94. PubMed ID: 23212113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
    Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
    Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility, gestation outcome and parasite congenital transmissibility in mice infected with TcI, TcII and TcVI genotypes of Trypanosoma cruzi.
    Cencig S; Coltel N; Truyens C; Carlier Y
    PLoS Negl Trop Dis; 2013; 7(6):e2271. PubMed ID: 23785533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.